As Wall Street awaits phase IIb data from Kala Bio Inc. with KPI-012 in persistent corneal epithelial defect, odds are being weighed for that candidate – and others in development – against the lone ...
In a major breakthrough in human tissue replication, for the first time ever a 3D-printed cornea has been transplanted onto a legally blind patient's eye, successfully restoring their sight. That's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results